Photo - Reopia Optics, Inc.
51979

Reopia Optics, Inc.

Prevent the global myopia pandemic with novel spectacles.

USA, California
Market: Medicine
Stage of the project: Idea or something is already done

Date of last change: 15.04.2021
Show contacts
0
equalizer from 2000
help
Calculated and estimated occupancy of the project (more about ratings)
My rating
1
2
3
4
5
6
7
8
9
10
Average rating:
 

Idea

Nearsightedness, or myopia, is exploding around the world. Unless the trend is stopped, 50% of the world’s population will be myopic by the year 2050. Ten percent of these myopes will be at high risk for blinding complications. In the past, children played outdoors for hours, whereas today they spend hours each day on smart phones and other digital display devices (whether indoors or outdoors). Reopia Optics is developing patented eyeglasses that will prevent the myopia pandemic.

Current Status

We have strong patent protection, prototypes for animal studies to be conducted in Singapore, initial interest from strategics, and an exceptional Scientific Advisory Board.

Market

All children at risk for developing myopia.

Problem or Opportunity

The worldwide pandemic of nearsightedness will lead to tremendous expenses and impact on quality of life unless we intervene. Reopia Optics spectacles can safely be worn by young children to prevent the development of myopia.

Solution (product or service)

Spectacles are easier and safer, especially in children from 4-12 years old, than alternatives such as contact lenses or eye drops.

Competitors

There are spectacles, eye drops, and contact lenses. Among spectacles, we have unique, patent protected technology that we anticipate will deliver superior results.

Advantages or differentiators

Reopia’s unique, patented spectacles are the only solution to deliver a powerful signal to the retina that suppresses myopic progression through the novel use of micro-lens arrays in combination with well defined, high contrast patterns, creating a targeted, augmented retinal image.

Finance

Selling Reopia spectacles to patients.

Business model

We will seek a distribution partner likely in the vision care space.

Money will be spent on

IP, Pre-clinical studies, technology optimization, clinical study.

Offer for investor

The Convertible Note will convert into equity at the value determined by terms of our first equity round, without discount or cap, but offering interest and a warrant.

Team or Management

Risks

New competitors enter the field with new technology.

Incubation/Acceleration programs accomplishment

Selected and completed the Health Wildcatters accelerator in Dallas TX.

Won the competition and other awards

Selected to present at OIS Myopia conference - https://ois.net/ois-myopia-management-showcase-2021/ .

Invention/Patent

16/052,407, 2019-0038123

16/366,972, US10,921,612

16/583,093, 2020-0089023

We are also filing a patent in China through the PCT

Photos

Photo 1 - Prevent the global myopia pandemic with novel spectacles.
5,00
1
2
3
4
5
1 voice
Sign in/Sign up
arrow_back
EN
more_horiz
close
visibility60
star0
Add to favorites
Delete from favorites
share
close
thumb_up0
Like
Unlike
Idea
Current Status
Market
Problem or Opportunity
Solution (product or service)
Competitors
Advantages or differentiators
Finance
Invested in previous rounds, $
Business model
Money will be spent on
Offer for investor
Team or Management
Mentors & Advisors
Lead investor
Risks
Incubation/Acceleration programs accomplishment
Won the competition and other awards
Invention/Patent
Photos
Product Video